Assay Development for Superior Understanding of Response and Efficacy (ASSURE)
Archived on January 2, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 1:00 PM UTC−05:00
- Posted
- November 17, 2025
- Notice type
- Solicitation
- Set-aside
- No Set aside used
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- ASPR BARDA DIV CONTRACTS MGMT & ACQ
- Place of performance
- South Carolina, 29486
- PSC
- AN42: R&D- MEDICAL: HEALTH SERVICES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Last updated
- Aug 21, 2026
Identifiers
- Solicitation number
- RRPV-26-07-ASSURE
- Notice ID
- 774b1c03c1b544e0b086a28eede6b5c8
Description
The ASSURE program aims to develop innovative, multiplexed, high-throughput, scalable and sample sparing assays that provide comprehensive evaluation of an individual’s immune status as a response to either infection or vaccination.
This program seeks to de-risk the development of novel assay platform technologies with the ultimate goal of establishing new, qualified assays primarily for BARDA and vaccine developers to comprehensively assess the immune response and status elicited by vaccines and/or infection due to CBRN threats, pandemic influenza, or other emerging infectious diseases. Some of these assays may lead to support of new correlates of protection.
Award Overview
Contacts
Contracting Officer
Primary Contact
Documents
Showing 1 of 1 items
Document | Source | Agency | Posted Date | File Size | Actions | |
|---|---|---|---|---|---|---|
| Solicitation | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | Nov 17, 2025 | 188.07 KB |
Lifecycle
RRPV-26-07-ASSURE- Solicitation
Award typically follows within 30–90 days after the response deadline. (estimate)
- SolicitationCurrentNov 17, 2025
Assay Development for Superior Understanding of Response and Efficacy (ASSURE)
Similar Opportunities
Additional Details
Solicitation Number
RRPV-26-07-ASSURE
Archive Date
Jan 2, 2026
Office Address
Washington, DC, 20515